LEXICON PHARMACEUTICALS, INC. Balance Sheet
LXRX|12 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$185M
FY2025
Cash
$34M
Cash and equivalents
Total Debt
$49M
FY2025
Shareholder Equity
$108M
FY2025
LEXICON PHARMACEUTICALS, INC. had $185M in total assets and $108M in shareholders' equity as of FY2025. Total debt was $49M against $34M in cash, resulting in $15M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34.3M | $66.7M | $22.5M | $64.1M | $46.6M | $203.0M | $137.3M | $37.5M | $30.4M | $186.3M | $47.2M | $100.6M |
| Accounts Receivable | $2.4M | $3.5M | $1.0M | $28.0K | $5.9M | $4.8M | $7.5M | $911.0K | $1.0M | $790.0K | $1.4M | $350.0K |
| Inventory | $281.0K | $231.0K | $381.0K | $4.2M | $4.7M | $1.9M | - | - | - | - | - | - |
| Current Assets | $101.9M | $246.2M | $176.5M | $140.9M | $173.3M | $322.0M | $357.9M | $532.4M | $369.0M | $134.6M | $230.9M | $285.8M |
| PP&E (Net) | $1.9M | $2.5M | $2.0M | $2.1M | $15.9M | $17.7M | $19.4M | $21.2M | $1.1M | $41.4M | $42.6M | $46.4M |
| Goodwill | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M |
| Total Assets | $185.0M | $298.4M | $229.4M | $194.3M | $284.1M | $436.5M | $475.6M | $654.8M | $471.4M | $274.2M | $371.8M | $430.5M |
| Current Liabilities | $20.9M | $45.2M | $31.5M | $23.2M | $36.8M | $124.1M | $164.6M | $123.0M | $45.0M | $19.3M | $18.3M | $21.4M |
| Total Debt | $49.4M | $100.3M | $99.5M | $234.2M | $243.9M | $231.6M | $85.2M | $103.8M | $87.5M | $20.2M | $21.9M | $23.5M |
| Shareholders' Equity | $107.5M | $145.9M | $93.1M | $117.1M | $167.5M | $285.9M | $284.0M | $170.2M | $266.7M | $297.6M | $297.6M | $247.0M |